» Authors » Will Foster

Will Foster

Explore the profile of Will Foster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mestre-Ferrandiz J, Czech M, Smolen J, Cornes P, Aapro M, Danese S, et al.
Expert Rev Pharmacoecon Outcomes Res . 2024 Jan; 24(4):509-519. PMID: 38284223
Introduction: Biosimilars have improved access to biologic medicines; however, historical thinking may jeopardize the viability of future markets. Areas Covered: An expert panel of eight diverse European stakeholders provided insights...
2.
Mestre-Ferrandiz J, Czech M, Smolen J, Cornes P, Aapro M, Danese S, et al.
Expert Rev Pharmacoecon Outcomes Res . 2024 Jan; 24(2):237-250. PMID: 38175140
Introduction: Approved biosimilars exhibit comparable efficacy, safety, and immunogenicity to reference products. This report provides perspectives on the societal value of biosimilars within Europe and potential factors that have influenced...
3.
Wilson D, Brewster N, Taylor R, Trevelyan A, Apostolakis M, Goyal D, et al.
Br J Cardiol . 2022 Jun; 28(4):43. PMID: 35747068
In order to evaluate the extent and causes of pain during cardiac implantable electronic device (CIED) implantation in our hospital, a prospective audit over a 23-month period using a patient...
4.
Al-Sheikhli J, Patchett I, Lim V, Marshall L, Foster W, Kuehl M, et al.
J Interv Card Electrophysiol . 2022 Feb; 66(3):551-559. PMID: 35192098
Background: The DiamondTemp ablation (DTA) catheter system delivers high power, open-irrigated, temperature-controlled radiofrequency (RF) ablation. This novel ablation system has not been previously used for ventricular tachycardia (VT) ablation. Objective:...
5.
Kwok C, Muntean E, Foster W, Mallen C
Crit Pathw Cardiol . 2022 Jan; 21(1):57-60. PMID: 35050949
A shared goal of patients, providers, and the companies that produce new therapies is to have these therapies used according to guidelines. Health services specialize in patient care and may...
6.
Lachlan T, He H, Aggour H, Sahota P, Harvey S, Patel K, et al.
J Arrhythm . 2021 Dec; 37(6):1522-1531. PMID: 34887957
Background: Transvenous lead extraction (TLE) for implantable cardiac-devices is traditionally performed under general anesthesia (GA). This can lead to greater risk of exposure to COVID-19, longer recovery-times and increased procedural-costs....
7.
Proietti R, Dowd R, Gee L, Yusuf S, Panikker S, Hayat S, et al.
J Interv Card Electrophysiol . 2021 Jan; 62(3):519-529. PMID: 33392856
Background: Substrate mapping has highlighted the importance of targeting diastolic conduction channels and late potentials during ventricular tachycardia (VT) ablation. State-of-the-art multipolar mapping catheters have enhanced mapping capabilities. The purpose...
8.
Adlan A, Arujuna A, Dowd R, Hayat S, Panikker S, Foster W, et al.
Open Heart . 2019 Nov; 6(2):e000996. PMID: 31673380
Background: Ventricular tachycardia (VT) is associated with increased morbidity and mortality. There is growing evidence for the effectiveness of catheter ablation in improving outcomes in patients with recurrent VT. Consequently...
9.
Proietti R, Adlan A, Dowd R, Assadullah S, Aldhoon B, Panikker S, et al.
J Interv Card Electrophysiol . 2019 Oct; 58(3):355-362. PMID: 31598876
Background: Defining diastolic slow-conduction channels within the borderzone (BZ) of scar-dependent re-entrant ventricular tachycardia (VT) is key for effective mapping and ablation strategies. Understanding wavefront propagation is driving advances in...
10.
Foster W, Lip G, Raza K, Carruthers D, Blann A
Eur J Clin Invest . 2011 Oct; 42(5):510-6. PMID: 21985471
Background: Endothelial dysfunction is present in established rheumatoid arthritis, but it is not clear at what stage of the disease this abnormality develops. We set out to determine whether endothelial...